InvestorQ : Can you tell me the reason for the sharp fall in Gland Pharma stock?
Riya Dwivedi made post

Can you tell me the reason for the sharp fall in Gland Pharma stock?

Answer
image
shrinidhi Rajan answered.
1 month ago
Follow

The Hyderabad based pharma company, Gland Pharma, touched a 52-week low of Rs1,943 per share, showing the sharpest fall since it got listed. For the Q2FY23 quarter, net profits fell to Rs241 crore amidst tepid sales and rising expenditure. The stock of Gland Pharma touched its lowest level of Rs1,730 per share since it got listed over 2 years back. The reason was EBIT margins contracting 500 basis points from 38% to 33%. Revenues and profits tapered due to supply chain constraints faced by Gland in the quarter, but the markets are far from impressed.

4 Views